Publications by authors named "Sachdev P Thomas"

Claim this Profile
P
Phase 2 multicentre study of single-agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance).
Cara A Rosenbaum, Sin-Ho Jung, Brandelyn Pitcher, Nancy L Bartlett, Sonali M Smith, Sachdev P Thomas

Br J Haematol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-Institutional, Prospective Clinical Utility Study Evaluating the Impact of the 92-Gene Assay (CancerTYPE ID) on Final Diagnosis and Treatment Planning in Patients With Metastatic Cancer With an Unknown or Unclear Diagnosis.
Sachdev P Thomas, Lauren E Jacobson, Anthony R Victorio, Theresa N Operaña, Brock E Schroeder

JCO Precis Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance).
Martin J Edelman, Xiaofei Wang, Lydia Hodgson, Richard T Cheney, Maria Q Baggstrom, Sachdev P Thomas, Thomas E Stinchcombe

J Clin Oncol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Enjoy glass of wine before eating:" a randomized trial to test the orexigenic effects of this advice in advanced cancer patients.
Aminah Jatoi, Rui Qin, Daniel Satele, Shaker Dakhil, Pankaj Kumar, Sachdev P Thomas

Support Care Cancer· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance).
Neal E Ready, Herbert H Pang, Lin Gu, Gregory A Otterson, Sachdev P Thomas

J Clin Oncol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II study of bortezomib in combination with paclitaxel, carboplatin, and concurrent thoracic radiation therapy for non-small-cell lung cancer: North Central Cancer Treatment Group (NCCTG)-N0321.
Yujie Zhao, Nathan R Foster, Jeffrey P Meyers, Sachdev P Thomas, Donald W Northfelt

J Thorac Oncol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of the oral MEK inhibitor selumetinib in advanced acute myelogenous leukemia: a University of Chicago phase II consortium trial.
Nitin Jain, Emily Curran, Neil M Iyengar, Ernesto Diaz-Flores, Rangesh Kunnavakkam, Sachdev P Thomas

Clin Cancer Res· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cediranib in patients with malignant mesothelioma: a phase II trial of the University of Chicago Phase II Consortium.
Nicholas P Campbell, Rangesh Kunnavakkam, Natasha Leighl, Mark D Vincent, David R Gandara, Sachdev P Thomas

Lung Cancer· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of triapine (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503.
Anne M Traynor, Ju-Whei Lee, Gerald K Bayer, John M Tate, Sachdev P Thomas

Invest New Drugs· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer.
Stephanie L Hines, Betty Anne Mincey, Jeff A Sloan, Sachdev P Thomas, Elaine Chottiner

J Clin Oncol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib, paclitaxel, and carboplatin as a first-line regimen for patients with metastatic esophageal, gastric, and gastroesophageal cancer: phase II results from the North Central Cancer Treatment Group (N044B).
Aminah Jatoi, Shaker R Dakhil, Nathan R Foster, Cynthia Ma, Kendrith M Rowland, Sachdev P Thomas

J Thorac Oncol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A University of Chicago consortium phase II trial of SB-715992 in advanced renal cell cancer.
Richard T Lee, Kathleen E Beekman, Maha Hussain, Nancy B Davis, Joseph I Clark, Sachdev P Thomas

Clin Genitourin Cancer· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mortality associated with daily bolus 5-fluorouracil/leucovorin administered in combination with either irinotecan or oxaliplatin: results from Intergroup Trial N9741.
Thierry Delaunoit, Richard M Goldberg, Daniel J Sargent, Roscoe F Morton, Charles S Fuchs, Sachdev P Thomas

Cancer· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis